LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 4.36 | 84.90 | 601 | 322 | 1.8632 | 1.7629 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 4.36 | 84.90 | 628 | 322 | 1.9469 | 1.8266 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 6.06 | 84.90 | 11 | 365 | 0.0301 | -0.6211 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 6.06 | 84.90 | 703 | 365 | 1.9236 | 1.7287 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 6.06 | 84.90 | 732 | 365 | 2.0030 | 1.7815 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.77 | 84.90 | 10 | 411 | 0.0243 | -0.6092 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.77 | 84.90 | 791 | 411 | 1.9235 | 1.6659 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.77 | 84.90 | 796 | 411 | 1.9356 | 1.6732 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 9.47 | 84.90 | 11 | 447 | 0.0246 | -0.5735 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 9.47 | 84.90 | 854 | 447 | 1.9087 | 1.6188 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 9.47 | 84.90 | 906 | 447 | 2.0249 | 1.6842 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 11.18 | 84.90 | 19 | 492 | 0.0386 | -0.4459 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 11.18 | 84.90 | 934 | 492 | 1.8970 | 1.5744 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 11.18 | 84.90 | 957 | 492 | 1.9437 | 1.5992 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.88 | 84.90 | 25 | 531 | 0.0471 | -0.3701 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.88 | 84.90 | 1017 | 531 | 1.9153 | 1.5570 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.88 | 84.90 | 1025 | 531 | 1.9303 | 1.5646 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.58 | 84.90 | 99 | 663 | 0.1492 | 0.0532 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.58 | 84.90 | 1068 | 663 | 1.6099 | 1.3483 | MN20160318_Q02 | E03 |